Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Subcutaneous Drug Delivery Market: By Product, By Distribution Channel, and Region Forecast 2020-2031
Subcutaneous Drug Delivery Market: By Product, By Distribution Channel, and Region Forecast 2020-2031
Subcutaneous Drug Delivery Market size was valued at US$ 32.7 billion in 2024 and is expected to reach US$ 51.3 billion by 2031, growing at a significant CAGR of 6.7% from 2025-2031. The Subcutaneous drug delivery system is a workable alternative for intravenous administration system. Fast development of biologics gives rise to the use of subcutaneous drug delivery. The use of this system is mainly preferred due to its benefits such as improves quality of life, allows self-medication and consequently lessens healthcare costs. A few major factors contribute towards the growth of the market are expediency and protection provided by this system for medical experts and patients. Several health experts are suffered from infectious illnesses in 2014 as a consequent of needle stick wounds according to World Health Organization and this unique system works effectively to lessen the prevalence of needle stick damages. Subcutaneous drugs are given in the skins layer named cutis, which contains the dermis and epidermis.
Study Period
2025-2031Base Year
2024CAGR
6.7%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
There are many significant factors that contribute towards the growth of the market and implementation of inorganic growth strategies by industry players is one of that. Key players focus more on inorganic strategies to give that important place to their products in the market. Growing focus on protecting the needle stick damage is given, which lead towards the growth of the market. Needle stick damages with lacing systems and injection needled are a major anxiety among diabetes patients. Growing alertness about safety and concern about needle stick damages are main factors booming the market growth. The unavailability of the approved products because of rising number of product recalls by different developers is a market restricting factor.
North America region dominated the market and obtained huge market share in the year 2019. This region is further anticipated to dominate the market during the forecast period. This region is evaluated to continue its dominance and maintained the market share because of the major key players working in the region, constant strategic initiatives followed by key players and developed healthcare infrastructure.
The market is also projected to grow at profitable level in Asia pacific also during the forecast period. Due to the increasing cases of diabetic people, huge market growth is observed in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 32.7 billion |
|
Market Size in 2031 |
US$ 51.3 billion |
|
Market CAGR |
6.7% |
|
By Product |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
Subcutaneous drug delivery market size was valued at US$ 32.7 billion in 2024 and is expected to reach US$ 51.3 billion by 2031, growing at a significant CAGR of 6.7%.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The key players of the market are Gerresheimer AG, Insulet Corporation, Ypsomed AG, Unilife Corporation, West Pharmaceutical Services, Inc., Novo Nordisk, Medtronic Plc Elcam Medical Group, Becton, Dickinson and Company, PharmaJet, Inolife Sciences.
Asia Pacific is the fastest-growing for the market.
| 1.Executive Summary |
| 2.Global Subcutaneous Drug Delivery Market Introduction |
| 2.1.Global Subcutaneous Drug Delivery Market - Taxonomy |
| 2.2.Global Subcutaneous Drug Delivery Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Distribution Channel |
| 2.2.3.Region |
| 3.Global Subcutaneous Drug Delivery Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Subcutaneous Drug Delivery Market Analysis, 2020-2024 and Forecast 2025-2031 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Subcutaneous Drug Delivery Market By Product, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 5.1. Pen injectors |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Auto-injectors |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Prefilled syringes |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Wearable injectors |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Needle-free Injectors |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6.Global Subcutaneous Drug Delivery Market By Distribution Channel, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 6.1. Online pharmacies |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hospital pharmacies |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Retail pharmacies |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Subcutaneous Drug Delivery Market By Region, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Subcutaneous Drug Delivery Market 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 8.1. Product Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Pen injectors |
| 8.1.2.Auto-injectors |
| 8.1.3.Prefilled syringes |
| 8.1.4.Wearable injectors |
| 8.1.5.Needle-free Injectors |
| 8.2. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Online pharmacies |
| 8.2.2.Hospital pharmacies |
| 8.2.3.Retail pharmacies |
| 8.3. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Subcutaneous Drug Delivery Market 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 9.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Pen injectors |
| 9.1.2.Auto-injectors |
| 9.1.3.Prefilled syringes |
| 9.1.4.Wearable injectors |
| 9.1.5.Needle-free Injectors |
| 9.2. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Online pharmacies |
| 9.2.2.Hospital pharmacies |
| 9.2.3.Retail pharmacies |
| 9.3. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Subcutaneous Drug Delivery Market 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Pen injectors |
| 10.1.2.Auto-injectors |
| 10.1.3.Prefilled syringes |
| 10.1.4.Wearable injectors |
| 10.1.5.Needle-free Injectors |
| 10.2. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Online pharmacies |
| 10.2.2.Hospital pharmacies |
| 10.2.3.Retail pharmacies |
| 10.3. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Subcutaneous Drug Delivery Market 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Pen injectors |
| 11.1.2.Auto-injectors |
| 11.1.3.Prefilled syringes |
| 11.1.4.Wearable injectors |
| 11.1.5.Needle-free Injectors |
| 11.2. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Online pharmacies |
| 11.2.2.Hospital pharmacies |
| 11.2.3.Retail pharmacies |
| 11.3. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Subcutaneous Drug Delivery Market 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Pen injectors |
| 12.1.2.Auto-injectors |
| 12.1.3.Prefilled syringes |
| 12.1.4.Wearable injectors |
| 12.1.5.Needle-free Injectors |
| 12.2. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Online pharmacies |
| 12.2.2.Hospital pharmacies |
| 12.2.3.Retail pharmacies |
| 12.3. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Gerresheimer AG |
| 13.2.2.Insulet Corporation |
| 13.2.3.Ypsomed AG |
| 13.2.4.Unilife Corporation |
| 13.2.5.West Pharmaceutical Services, Inc. |
| 13.2.6.Novo Nordisk |
| 13.2.7.Medtronic Plc |
| 13.2.8.Elcam Medical Group |
| 13.2.9.Becton, Dickinson and Company |
| 13.2.10.PharmaJet |
| 13.2.11.Inolife Sciences |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.